Square Pharmaceuticals PLC 2024 AR2

The report highlights Square Pharmaceuticals PLC's performance for the fiscal year ended June 30, 2024, during which the company maintained its leading position in the Bangladeshi pharmaceutical market. Despite a decline in standalone profit due to strategic product transfers to its subsidiary, Square Lifesciences Ltd., consolidated revenue grew by 15.47% to BDT 70.10 billion. The company advanced its sustainability initiatives by integrating IFRS S1 and S2 guidelines, focusing on climate change, water conservation, and waste management. Additionally, Square Pharmaceuticals continued its commitment to social responsibility through community sponsorships, disaster response, and human capital development.

Company: Square Pharmaceuticals PLC

Sector: Health Care

Country: Bangladesh

Year: 2024

Type: AR2

Pages: 170

Back to company

Square Pharmaceuticals PLC

Square Pharmaceuticals PLC 2024 Annual Report

Annual Report

The report highlights Square Pharmaceuticals PLC's performance for the fiscal year ended June 30, 2024, during which the company maintained its leading position in the Bangladeshi pharmaceutical market. Despite a decline in standalone profit due to strategic product transfers to its subsidiary, Square Lifesciences Ltd., consolidated revenue grew by 15.47% to BDT 70.10 billion. The company advanced its sustainability initiatives by integrating IFRS S1 and S2 guidelines, focusing on climate change, water conservation, and waste management. Additionally, Square Pharmaceuticals continued its commitment to social responsibility through community sponsorships, disaster response, and human capital development.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2024

Reporting Period

Jul 1, 2023 - Jun 30, 2024

Fiscal Year

2024

Published

Nov 27, 2024

Type

Annual Report with Sustainability Disclosures

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Water Consumption

Women in Management

Employees